NAOV Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	15 902.00
Średni wolumen	60 407.00
Kapitalizacja rynkowa	2.11M
EPS	$0 ( 2024-04-01 )
Następna data zysków	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.360
ATR14	$0.0120 (1.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Mika Thomas	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Jacob Harold	Buy	6 667	Option to Purchase Common Stock
2024-01-23	Schroeder Maria	Buy	16 667	Option to Purchase Common Stock
2024-01-23	Ferguson Michael	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Goldstein Martin M	Buy	16 667	Option to Purchase Common Stock

INSIDER POWER
29.17
Last 97 transactions
Buy: 2 103 083 \| Sell: 846 526

Nanovibronix Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanovibronix Inc Finanse

Annual	2023
Przychody:	$2.28M
Zysk brutto:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2023
Przychody:	$2.28M
Zysk brutto:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2022
Przychody:	$752 000
Zysk brutto:	$167 000 (22.21 %)
EPS:	$-3.84

FY	2021
Przychody:	$1.70M
Zysk brutto:	$770 000 (45.43 %)
EPS:	$-0.570

Financial Reports:

No articles found.

Nanovibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.